NCT06931808 2025-04-17
Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer
First Affiliated Hospital of Ningbo University
Phase 4 Enrolling by invitation
Clinical Trials
25 trialsNCT06893354 2025-03-25
Explore the Mechanisms Underlying Disease Resistance and Potential Primary Resistance Mechanism of Induction Therapy Lorlatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Positive Mutation Revealed by Single-cell RNA Sequencing and Spatial Transcriptomics
The First Affiliated Hospital of Guangzhou Medical University
Phase 4 Not yet recruiting
NCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
NCT03691441 2023-05-17
Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer
Universitätsklinikum Hamburg-Eppendorf
Phase 4 Unknown
NCT05840068 2023-05-03
IGF Level in Breast Cancer Patients Treated With Metformin
Beni-Suef University
Phase 4 Completed
NCT05036005 2023-04-18
NeoON
Institut fuer Frauengesundheit
Phase 4 Unknown
NCT05429515 2022-06-23
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
Peking Union Medical College Hospital
Phase 4 Not yet recruiting
NCT05098990 2021-10-29
Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT03986528 2021-02-23
Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase 4 Unknown
NCT00380874 2021-02-11
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
Pfizer
Phase 4 Terminated
NCT04134247 2019-10-22
Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL
Shandong Provincial Hospital
Phase 4 Unknown
NCT03799692 2019-01-10
Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer
Fudan University
Phase 4 Unknown
NCT03401827 2018-02-12
The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer
Seoul National University Hospital
Phase 4 Unknown
NCT00510627 2017-03-03
Prometheus
Boston Scientific Corporation
Phase 4 Withdrawn
NCT01665417 2017-02-08
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02782845 2016-11-21
An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)
Hoffmann-La Roche
Phase 4 Completed
NCT02860429 2016-08-09
Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma
The First Affiliated Hospital of Dalian Medical University
Phase 4 Unknown
NCT02000531 2016-01-13
Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population
Hoffmann-La Roche
Phase 4 Completed
NCT01501136 2015-07-17
CTTNKTL-I/II
Zhengzhou University
Phase 4 Unknown
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02283424 2014-11-05
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
Chinese PLA General Hospital
Phase 4 Unknown
NCT00664911 2013-10-16
OLD
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 4 Completed
NCT00894153 2012-04-09
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown
NCT00902083 2012-04-09
rAd-p53
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown
NCT00911092 2012-01-02
COL06-13
Centre Oscar Lambret
Phase 4 Completed